Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2014
11/18/2014US8889623 Immunostimulatory nanoparticles and related compositions, methods and systems
11/18/2014US8889398 Composition for inactivating an enveloped virus
11/18/2014US8889196 Dental composites comprising nanoparticles of amorphous calcium phosphate
11/18/2014US8889193 Sustained delivery of therapeutic agents to an eye compartment
11/18/2014US8889192 Magnetic nanomedicine for inhibiting/treating human prostate cancer
11/18/2014US8889191 Sustained-release formulations of topiramate
11/18/2014US8889189 Dissolution composition for examining drug solubility
11/18/2014US8889182 Process of thermodynamical activation of water-insoluble drugs loaded into cross-linked polymers
11/18/2014US8889181 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
11/18/2014US8889175 Nanoparticulate in-situ gels as vitreous humor substitutes for ocular diseases
11/18/2014US8889174 Zero-order prolonged release coaxial implants
11/18/2014US8889173 Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
11/18/2014US8889170 Implantable device having a coating with a triblock copolymer
11/18/2014US8889161 Microencapsulated compositions and methods for tissue mineralization
11/18/2014US8889159 Compositions and methods for treating hepatitis C virus
11/18/2014US8889155 Gel composition for treating mycosis
11/18/2014US8889152 Capsular polysaccharides solubilisation and combination vaccines
11/18/2014US8889140 Compositions and methods for tissue repair
11/18/2014US8889129 Antidotes for factor Xa inhibitors and methods of using the same
11/18/2014US8889127 Targeted protein replacement for the treatment of lysosomal storage disorders
11/18/2014US8889123 Compositions and soft tissue replacement methods
11/18/2014US8889117 Modular nanoparticles for adaptable vaccines
11/18/2014US8889115 Ion binding polymers and uses thereof
11/18/2014US8889105 Bacteriophage compositions for treatment of bacterial infections
11/18/2014US8889101 Dendrimer based nanodevices for therapeutic and imaging purposes
11/18/2014US8889099 Methods and compositions for delivering peptides
11/13/2014US20140336571 Compositions and methods for delivery of hydrophobic active agents
11/13/2014US20140336356 Peptide agonists of glp-1 activity
11/13/2014US20140336278 In Situ Gelling Drug Delivery System
11/13/2014US20140336277 Radiopaque iodinated and iodide-containing crystalline absorbable aliphatic polymeric materials and applications thereof
11/13/2014US20140336276 IN SITU CROSSLINKING HYDROGEL COMPRISING gamma-POLYGLUTAMIC ACID AND METHOD FOR PRODUCING THE SAME
11/13/2014US20140336274 Process for producing inorganic particulate material
11/13/2014US20140336273 Anhydrous sodium carbonate having a low pore content
11/13/2014US20140336268 Formulations of vitamin k analogs for topical use
11/13/2014US20140336264 Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
11/13/2014US20140336223 Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
11/13/2014US20140336163 Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
11/13/2014US20140336161 Pharmaceutical formulations containing corticosteroids for topical administration
11/13/2014US20140336151 Silicon-Containing Fumaric Acid Esters
11/13/2014US20140336149 Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process
11/13/2014US20140336144 External Preparation Containing NSAIDS And Method For Producing The External Preparation
11/13/2014US20140336131 Methods for treating inflammation, autoimmune disorders and pain
11/13/2014US20140336127 Stabilized Peptide Helices For Inhibiting Dimerization Of Chemokine C Motif Receptor 2 (CCR2)
11/13/2014US20140336114 Buffers for Controlling the pH of Bone Morphogenetic Proteins
11/13/2014US20140336107 Glp-1 receptor agonist peptide gastrin conjugates
11/13/2014US20140335206 Topical analgesic composition
11/13/2014US20140335194 Polymeric nanoparticle solution composition and its manufacturing process
11/13/2014US20140335189 Intestinal peptide targeting ligands
11/13/2014US20140335186 Methods and compositions for enhancing cd4+ regulatory t cells
11/13/2014US20140335182 Aqueous polymer dispersion based on n,n-diethylaminoethyl methacrylate, its preparation and use
11/13/2014US20140335178 Dosage forms of apixaban
11/13/2014US20140335173 Release capsules, manufacture and uses thereof
11/13/2014US20140335166 Methods of Making and Using Nano Scale Particles
11/13/2014US20140335164 Liposomes and its production method
11/13/2014US20140335162 Pharmaceutical composition for treatment of allergic reactions
11/13/2014US20140335160 Biodegradable Nanoparticles as Novel Hemoglobin-Based Oxygen Carriers and Methods of Using the Same
11/13/2014US20140335159 Biodegradable Nanoparticles as Novel Hemoglobin-Based Oxygen Carriers and Methods of Using the Same
11/13/2014US20140335158 Protein and Nucleic Acid Delivery Vehicles, Components and Mechanisms Thereof
11/13/2014US20140335157 Cationic lipid having improved intracellular kinetics
11/13/2014US20140335153 Thin film with high load of active ingredient
11/13/2014US20140335152 Methods and compositions for enhancing the uptake of therapeutic agents by target cells
11/13/2014US20140335151 Patch containing non-steroidal anti-inflammatory drug
11/13/2014US20140335148 Bioactive substance-containing nanofibers and uses thereof
11/13/2014US20140335140 Natural volatile plant oils to repel arthropods
11/13/2014US20140335135 Pharmaceutical composition
11/13/2014US20140335133 Low-oil pharmaceutical emulsion compositions comprising progestogen
11/13/2014US20140335132 Binding drugs with nanocrystalline cellulose (ncc)
11/13/2014US20140335127 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
11/13/2014US20140335109 Combination of inotuzumab ozogamicin and torisel for the treatment of cancer
11/13/2014US20140335108 Utility of insulin-like 6 (insl6) for the treatment of autoimmune diseases
11/13/2014US20140335086 Modified heat shock protein-antigenic peptide complex
11/13/2014US20140335056 Sustained releasing pharmaceutical composition
11/13/2014US20140335051 Synergistic biomolecule-polymer conjugates
11/13/2014US20140335045 bFGF-POLYMER CONJUGATES, METHODS FOR MAKING THE SAME AND APPLICATIONS THEREOF
11/13/2014US20140335031 Liquid solution comprising peba
11/13/2014US20140335025 Targeting corroles for tumor toxicity and mri
11/13/2014US20140335014 Il-1 alpha dual variable domain immunoglobulins and uses thereof
11/13/2014US20140334976 Sterilizer, oral cavity sterilizer, sterilization method, sterilization apparatus, and sterilizer evaluation method
11/11/2014US8883971 CTLA4 proteins and their uses
11/11/2014US8883967 Branched amphipathic oligo-peptides that self-assemble into vesicles
11/11/2014US8883964 Compositions comprising modified collagen and uses therefor
11/11/2014US8883863 Safety of psuedoephedrine drug products
11/11/2014US8883861 Iminic monomers and polymers thereof
11/11/2014US8883860 Method for purifying diatomaceous earth
11/11/2014US8883856 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
11/11/2014US8883849 Treatment of sleep disturbances
11/11/2014US8883838 Pharmaceutical cream compositions and methods of use
11/11/2014US8883834 Methods and compositions for locally increasing body fat
11/11/2014US8883830 Topical therapy for the treatment of migraines, muscle sprains, muscle spasms, spasticity and related conditions
11/11/2014US8883825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
11/11/2014US8883767 Low ether compositions and delivery apparatus
11/11/2014US8883761 Use of lipid conjugates in the treatment of diseases associated with vasculature
11/11/2014US8883729 Nanolipoprotein particles and related compositions, methods and systems
11/11/2014US8883728 Intranasal administration of active agents to the central nervous system
11/11/2014US8883723 Conjugate of insulin and vitamin B12 for oral delivery
11/11/2014US8883715 Biocompatible polymers, process for their preparation and compositions containing them
11/11/2014US8883426 Use of therapeutically effective lipids and method for producing organ-/tissue-specific therapeutically effective lipids
11/11/2014US8883307 Spherical particle of crystalline mannitol
11/11/2014US8883224 Topical skin care formulations comprising plant extracts
11/11/2014US8883221 Micronutrient combination product for use as a dietetic food supplement in age-related macular degeneration
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 1712